1. Richard V Paul, David W Ploth. The renal circulation. In: Massry SG, Glassock RJ, Textbook of Nephrology. 4th Edition. Lippincott Williams & Wilkins. 2001, pp:43-55.
2. Wai Y Tse, Dwomoa Adu. Non-steroidal anti-inflammtory drugs and the kidney. In: Davison AM, Cameron JS, Grünfeld JP, Ponticelli C, Ritz E, Winearls CG, van Ypersele C. Oxford Textbook of Clinical Nephrology. 3rd Edition. Oxford University Press Inc., New York. 2005. pp:1049-1059.
3. Deepak K Malhotra, William L Henrich. Nephropathies of the nonsteroidal antiinflammatory agents. In: Massry SG, Glas-sock RJ, Textbook of Nephrology. 4th Edition. Lippincott
46
Türk Nefroloji Diyaliz ve Transplantasyon Dergisi /Official Journal of the Turkish Society of Nephrology
Akut Böbrek Yetmezliği ve Non-Steroid Antiinflamatuar İlaçlar £
Williams & Wilkins. 2001, pp: 921-925.
4. Burton D Rose. NSAIDs: Acute renal failure and nephritic syndrome, www.UpToDate.com
5. Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A.
Th
e outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 2000 Sep;54(3):179-90.
6. Marc E De Broe. Drug induced nephropathies. In: Davison
AM, Cameron JS, Grünfeld JP, Ponticelli C, Ritz E, Winearls
CG, van Ypersele C, Oxford Textbook of Clinical Nephro-logy. 3rd Edition. Oxford University Press Inc., New York. 2005. pp:2581-2599.
7. Whelton A, Watson AJ. Nonsteroidal anti-inflammatory drugs: effects on kidney function. In: ME De Broe, GA Porter, WM Bennett, GA Verpooten (Eds), Clinical Nephrotoxins-Renal Injury from Drugs and Chemicals. Dordrecht: Kluwer Acade¬mic Publishers, 1998. pp. 203-216.
8. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13-24.
9. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kuju-bu D, Antes L, Lasseter KC, Quan H, Gertz BJ, FitzGerald GA. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Phar¬macol Exp Ther 1999;289(2):735-41.
10. Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musli-
ner TA, Gertz BJ, Brater DC, Yao SL. Effect of cyclooxygena-se-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Ann Intern Med. 2000;133(1):1-9.
11. Pearce CJ, Gonzale FM, Wallin JD. Renal failure and hyper-kalemia associated with ketorolac tromethamine. Archives of
Internal Medicine 1993;153:1000-1002.
12. O'Callaghan CA, Andrews PA, Ogg CS Renal disease and use of topical non-steroidal anti-inflammatory drugs. BMJ 1994;
308(6921):110-1.
13. Kleinknecht D, Landais P, Goldfarb B. Analgesic and non-ste-roidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study. Clin Nephrol. 1986;25(6): 275-81. Erratum in: Clin Nephrol 1987;27(1):46.
14. Huerta C, Castellsague J, Varas-Lorenzo C, Garcia Rodrigu¬ez LA. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis
2005;45(3):531-9.
15. Gambaro G, Perazella MA. Adverse renal effects of antiinflammatory agents: evaluation of selective and non-selective cyclooxygenase inhibitors. J Intern Med 2003;253(6):643-52.
Thank you for copying data from http://www.arastirmax.com
